Osteoporosis Prevention refers to measures intended to reduce the probability of developing osteoporosis and fragility fractures by maintaining bone strength, identifying risk factors and addressing reversible contributors to skeletal deterioration. Osteoporosis is characterised by reduced bone strength and increased susceptibility to fracture, with bone mineral density being an important but incomplete component of risk. Bone is living tissue that is continuously remodelled through coordinated activity of cells responsible for resorption and formation. Prevention therefore begins well before a fracture occurs and spans nutrition, physical activity, fall prevention, medication review and assessment of individual fracture risk.
Bone mass develops substantially during childhood and early adulthood, making the years before peak bone mass an important period for lifelong skeletal health. Genetic factors strongly influence bone size, structure and density, while nutrition, physical activity, hormonal status and general health also contribute. Bone mass commonly declines with age, and loss can accelerate around menopause because reduced oestrogen changes the balance between bone resorption and formation. Age-related changes also affect muscle strength and balance, increasing the consequences of a fall even when bone density itself is not severely reduced.
Adequate calcium and vitamin D are important for normal skeletal physiology, but more is not automatically better. Calcium provides mineral substrate for bone, while vitamin D supports calcium absorption and contributes to normal bone metabolism. Dietary sources are generally preferred when sufficient, and supplementation may be considered where dietary intake or vitamin D status is inadequate or clinical circumstances create increased requirements. Excessive supplementation can have disadvantages, so prevention should not be reduced to taking calcium tablets or vitamin preparations without considering diet, risk factors and individual circumstances.
Weight-bearing and resistance exercise are important because mechanical loading stimulates bone adaptation and helps preserve muscle function. Activities such as walking, climbing stairs and resistance training can contribute to skeletal health, while balance exercises can reduce fall risk. Exercise programmes should be appropriate to age, physical ability and existing fracture risk. In established severe osteoporosis, activities involving high impact, extreme spinal flexion or unsafe loading may require professional modification. Exercise therefore has two preventive roles: supporting bone and improving the strength, coordination and stability that reduce the likelihood of injurious falls.
Lifestyle factors can substantially affect skeletal risk. Smoking is associated with poorer bone health, while excessive alcohol consumption can increase fracture risk through effects on bone, balance and general health. Very low body weight can be associated with lower bone mass and greater fracture susceptibility. Certain diets, eating disorders, prolonged inactivity and illnesses that impair nutrient absorption can also contribute. Prevention is consequently broader than maintaining a particular bone-density measurement and includes maintaining adequate nutrition, muscle function, healthy body composition and general physical health.
Some medicines and medical conditions can accelerate bone loss. Long-term systemic glucocorticoid treatment is a particularly important example because it can reduce bone formation and increase fracture risk. Other conditions affecting endocrine function, nutrient absorption, kidney function or sex hormones can also influence skeletal health. People at increased risk may undergo bone mineral density assessment using dual-energy X-ray absorptiometry, and clinical fracture-risk tools can combine density with age, previous fractures and other factors. Preventive treatment is determined by overall fracture risk rather than by density alone.
A common misconception is that osteoporosis is simply a normal and unavoidable part of ageing. Although bone loss is common with ageing, osteoporosis and fragility fractures are not inevitable, and modifiable risks can be addressed. Another misconception is that a normal bone mineral density guarantees immunity from fracture. Bone strength also depends on bone architecture, turnover, falls, muscle function, medications and previous fracture history. Conversely, a low density result does not by itself describe every aspect of an individual's skeletal condition.
Effective prevention is therefore a life-course process involving early development of healthy bone, preservation of bone and muscle with age, identification of high-risk periods and targeted clinical intervention when appropriate. Prevention also includes reducing opportunities for falls through appropriate footwear, environmental modifications, vision assessment and attention to balance where relevant. Pharmacological treatment may be used for people whose fracture risk is sufficiently high, and several classes of medicines can reduce fracture risk through different effects on bone remodelling. The central principle is that preventing osteoporosis-related disability involves both preserving skeletal strength and preventing the falls and other events that can turn reduced bone strength into a fracture.
